Figure 3. BMMC therapy increases cellularity in BALF, LDH activity and does not alter myeloperoxidase activity.

Quantification of (A) total number of cells, (B) mononuclear cells and (C) polymorphonuclear cells in BALF. Quantification of (D) myeloperoxidase and (E) LDH activity. Mice in the control (C) and silica (SIL) groups received saline or silica intratracheally. C and SIL animals were treated with BMMCs (1×10⁶ cells i.v., C+BMMC and SIL+BMMC). Data are presented as the mean ± SEM. n = 7 animals per group. ^#Significantly different from C. ^##Significantly different from SIL40d and SIL70d.